Skip to content

Chimney Trial of Parastomal Hernia Prevention

Chimney Trial - Randomized, Controlled, Multi Center Trial of Parastomal Hernia Prevention

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03799939
Enrollment
141
Registered
2019-01-10
Start date
2019-02-05
Completion date
2026-07-31
Last updated
2024-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominoperineal Resection, Parastomal Hernia, Rectal Adenocarcinoma

Brief summary

Chimney trial is designed to compare the effectiveness and safety of specifically designated polyvinylidene fluoride mesh (PVDF, Dynamesh IPST) to controls in a multi center, randomized setting.

Detailed description

The European Hernia Society recommends the use of prophylactic mesh when permanent colostomy is made. The results of previous trials using keyhole technique are partially unsatisfactory. Specifically designed PVDF mesh used in this trial showed promising results in previous small trial. Chimney trial is designed to compare the effectiveness and safety of mesh group to controls operated with no preventive mesh in parastomal hernia prevention after laparoscopic or robotic-assisted abdominoperineal resection or low Haartman's procedure for rectal adenocarcinoma.

Interventions

DEVICEIntervention group

Polyvinylidene fluoride mesh (Dynamesh IPST) is used on intraperitoneal onlay position to prevent parastomal hernia.

Sponsors

University of Oulu
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

Participants are unaware of the randomization group.

Intervention model description

Chimney trial is a prospective randomized controlled multicenter trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * Rectal adenocarcinoma with curative intent laparoscopic or robotic assisted abdominoperineal resection or low Hartmann´s operation and permanent colostomy * Patient has a life expectancy of at least 12 months. * Patient must sign Informed consent before any study procedures and agrees to attend all study visits

Exclusion criteria

* Abdominoperineal resection or Hartmann's operation by laparotomy or conversion to laparotomy * Complication requiring laparotomy during post surgery treatment at surgical ward after APR * Patient with a comorbid illness or condition that would preclude the use of surgery (ASA 4-5). * Patients with concurrent or previous malignant tumors within 5 years before study enrollment * Patients with T4b tumors which impose a multi-organ resection * Rectal malignancy other than adenocarcinoma * Patient undergoing emergency procedures * Planned rectal surgery along with major concomitant procedures (e.g. hepatectomies, other intestinal resections). * Metastatic disease with no possibility of curative surgery * Pregnant or suspected pregnancy * Patients living geographically distant and/or unwilling to return for follow-ups or comply with all study requirements * Active abdominal infection at the time of surgery * Previous surgery at the colostomy site * Language barrier or other reasons why informed consent is not possible

Design outcomes

Primary

MeasureTime frameDescription
Incidence of parastomal hernia12 monthsIncidence of parastomal hernia at 12 months follow up

Secondary

MeasureTime frameDescription
Surgical site infection rate30 daysSurgical site infections measured by Clavien-Dindo Classification
Complications30 daysComplications measured by Clavien-Dindo Classification
Stoma related complications5 yearsStoma related complications measured by Clavien-Dindo Classification
Reoperation rate5 yearsNeed for reoperations
Operative time1 dayOperative time
Incidence of parastomal hernia at long term follow up5 yearsIncidence of parastomal hernia during 5 years of follow up
Rand 36 quality of life5 yearsQuality of life measured by Rand-36 quality of life questionnaire
Quality of life measured by Colostomy impact score5 yearsQuality of life measured by Colostomy impact score
Medico-economic substudy5 yearsMedico-economic substudy including both short and long term costs included in both groups
Radiological substudy of stoma distance3 yearsDistance of stoma from midline defined by umbilicus
Radiological substudy of adipose tissue thickness3 yearsThickness of adipose tissue on computer tomography scan on contralateral site of stoma
Length of stay30 daysLength of stay at the hospital

Countries

Finland, Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 23, 2026